Tiziana Life Sciences - Common Shares (TLSA) closed at $0.87 on October 27, 2026, down 1.1% from the previous close, on volume of 183,593 shares (30-day average 649,920).
Data as of October 27, 2026.
27-Oct-2026
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
Globe Newswire (Wed, 21-Oct 7:00 AM ET)
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer's Disease
Globe Newswire (Fri, 16-Oct 7:00 AM ET)
Globe Newswire (Wed, 30-Sep 7:00 AM ET)
Globe Newswire (Mon, 28-Sep 7:00 AM ET)
Globe Newswire (Mon, 21-Sep 7:00 AM ET)
Tiziana’s RRMS collaboration plan adds a new clinical angle for intranasal foralumab
Market Chameleon (Thu, 17-Sep 6:25 AM ET)
Globe Newswire (Thu, 17-Sep 7:00 AM ET)
Globe Newswire (Mon, 24-Aug 7:00 AM ET)
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Globe Newswire (Tue, 4-Aug 7:00 AM ET)
Globe Newswire (Fri, 31-Jul 7:00 AM ET)
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
Tiziana Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol TLSA.
As of October 27, 2026, TLSA stock price declined to $0.87 with 183,593 million shares trading.
TLSA has a beta of 1.22, meaning it tends to be more sensitive to market movements. TLSA has a correlation of 0.05 to the broad based SPY ETF.
TLSA has a market cap of $110.96 million. This is considered a Micro Cap stock.
In the last 3 years, TLSA traded as high as $2.60 and as low as $.41.
TLSA has underperformed the market in the last year with a price return of -53.9% while the SPY ETF gained +13.4%. TLSA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.2% and -20.0%, respectively, while the SPY returned +4.4% and -1.1%, respectively.
TLSA support price is $.84 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLSA shares will trade within this expected range on the day.
